These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 23702826

  • 1. Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor.
    Lamdan H, Gavilondo JV, Muñoz Y, Pupo A, Huerta V, Musacchio A, Pérez L, Ayala M, Rojas G, Balint RF, Larrick JW.
    Mol Biosyst; 2013 Aug; 9(8):2097-106. PubMed ID: 23702826
    [Abstract] [Full Text] [Related]

  • 2. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
    Kim HS, Lo SC, Wear DJ, Stojadinovic A, Weina PJ, Izadjoo MJ.
    J Immunol Methods; 2011 Sep 30; 372(1-2):146-61. PubMed ID: 21787781
    [Abstract] [Full Text] [Related]

  • 3. Isolation of a novel neutralizing antibody fragment against human vascular endothelial growth factor from a phage-displayed human antibody repertoire using an epitope disturbing strategy.
    Lamdan H, Ayala M, Rojas G, Munoz Y, Morera Y, Guirola O, Chinea G, Gavilondo JV.
    J Biotechnol; 2011 Jan 20; 151(2):166-74. PubMed ID: 21167224
    [Abstract] [Full Text] [Related]

  • 4. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD, Wu YY, Tsai YJ, Tsai YS, Lin YY, Lai SL, Huang CY, Lok YY, Hu CY, Lai JS.
    Int J Mol Sci; 2016 Feb 05; 17(2):214. PubMed ID: 26861297
    [Abstract] [Full Text] [Related]

  • 5. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
    Kim HS, Tsai S, Zou N, Lo SC, Wear DJ, Izadjoo MJ.
    J Immunol Methods; 2011 Feb 28; 365(1-2):101-9. PubMed ID: 21172353
    [Abstract] [Full Text] [Related]

  • 6. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB.
    J Mol Biol; 1999 Nov 05; 293(4):865-81. PubMed ID: 10543973
    [Abstract] [Full Text] [Related]

  • 7. Design of synthetic autonomous VH domain libraries and structural analysis of a VH domain bound to vascular endothelial growth factor.
    Ma X, Barthelemy PA, Rouge L, Wiesmann C, Sidhu SS.
    J Mol Biol; 2013 Jun 26; 425(12):2247-59. PubMed ID: 23507309
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X, Campoli M, Ko E, Luo W, Ferrone S.
    J Immunol Methods; 2004 Nov 26; 294(1-2):23-35. PubMed ID: 15604013
    [Abstract] [Full Text] [Related]

  • 9. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
    Lu D, Shen J, Vil MD, Zhang H, Jimenez X, Bohlen P, Witte L, Zhu Z.
    J Biol Chem; 2003 Oct 31; 278(44):43496-507. PubMed ID: 12917408
    [Abstract] [Full Text] [Related]

  • 10. Phage-derived fully human antibody scFv fragment directed against human vascular endothelial growth factor receptor 2 blocked its interaction with VEGF.
    Zhang J, Li H, Wang X, Qi H, Miao X, Zhang T, Chen G, Wang M.
    Biotechnol Prog; 2012 Jul 31; 28(4):981-9. PubMed ID: 22581629
    [Abstract] [Full Text] [Related]

  • 11. The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding.
    Davydova N, Roufail S, Streltsov VA, Stacker SA, Achen MG.
    J Mol Biol; 2011 Apr 08; 407(4):581-93. PubMed ID: 21315726
    [Abstract] [Full Text] [Related]

  • 12. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
    Erdag B, Balcioglu BK, Bahadir AO, Serhatli M, Kacar O, Bahar A, Seker UO, Akgun E, Ozkan A, Kilic T, Tamerler C, Baysal K.
    Biotechnol Appl Biochem; 2011 Apr 08; 58(6):412-22. PubMed ID: 22172104
    [Abstract] [Full Text] [Related]

  • 13. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
    Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, Crawford RS, Weiner LM, Marks C, Marks JD.
    J Mol Biol; 1996 Nov 08; 263(4):551-67. PubMed ID: 8918938
    [Abstract] [Full Text] [Related]

  • 14. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H, Rajabibazl M, Ebrahimizadeh W, Dehbidi GR.
    Microvasc Res; 2015 Jan 08; 97():13-8. PubMed ID: 25250517
    [Abstract] [Full Text] [Related]

  • 15. Reducing epitope spread during affinity maturation of an anti-ganglioside GD2 antibody.
    Hu J, Huang X, Ling CC, Bundle DR, Cheung NK.
    J Immunol; 2009 Nov 01; 183(9):5748-55. PubMed ID: 19812201
    [Abstract] [Full Text] [Related]

  • 16. Cloning and characterization of a single-chain fragment of monoclonal antibody to ACE suitable for lung endothelial targeting.
    Balyasnikova IV, Berestetskaya JV, Visintine DJ, Nesterovitch AB, Adamian L, Danilov SM.
    Microvasc Res; 2010 Dec 01; 80(3):355-64. PubMed ID: 20888351
    [Abstract] [Full Text] [Related]

  • 17. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
    Juárez-González VR, Riaño-Umbarila L, Quintero-Hernández V, Olamendi-Portugal T, Ortiz-León M, Ortíz E, Possani LD, Becerril B.
    J Mol Biol; 2005 Mar 11; 346(5):1287-97. PubMed ID: 15713481
    [Abstract] [Full Text] [Related]

  • 18. Array-In-Well Epitope Mapping of Phage-Displayed Antibodies.
    Lamminmäki U, Batra G, Saviranta P.
    Methods Mol Biol; 2018 Mar 11; 1785():129-140. PubMed ID: 29714016
    [Abstract] [Full Text] [Related]

  • 19. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S, Kirchhofer D, Hass P, Lipari T, Moran P, Nagel M, Judice K, Schroeder K, Tom J, Lowman H, Adams C, Eaton D, Devaux B.
    Blood Coagul Fibrinolysis; 2000 Jan 11; 11(1):27-42. PubMed ID: 10691097
    [Abstract] [Full Text] [Related]

  • 20. Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.
    Rinderknecht M, Villa A, Ballmer-Hofer K, Neri D, Detmar M.
    PLoS One; 2010 Aug 02; 5(8):e11941. PubMed ID: 20689828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.